Mammalian target of rapamycin overexpression antagonizes chronic hypoxia-triggered pulmonary arterial hypertension via the autophagic pathway

Li,Lingxia; Wang,Xiaochuang; Wang,Lina; Qu,Li; Zhu,Xinye; Li,Manxiang; Dang,Xiaoyan; Li,Ping; Gao,Yanxia; Peng,Zhuo; Pan,Longfei; Wan,Li

doi:10.3892/ijmm.2015.2224

Mammalian target of rapamycin overexpression antagonizes chronic hypoxia-triggered pulmonary arterial hypertension via the autophagic pathway

Authors:
- Lingxia Li
- Xiaochuang Wang
- Lina Wang
- Li Qu
- Xinye Zhu
- Manxiang Li
- Xiaoyan Dang
- Ping Li
- Yanxia Gao
- Zhuo Peng
- Longfei Pan
- Li Wan
View Affiliations

Affiliations: The Cadre Ward, The Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China, Department of Emergency Medicine, The Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China, Department of Respiratory Diseases, The Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China
Published online on: May 26, 2015 https://doi.org/10.3892/ijmm.2015.2224
Pages: 316-322

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disorder with high morbidity and mortality, and is characterized by excessive growth of endothelial cells. Recently, the mammalian target of rapamycin (mTOR) has attracted increasing attention due to its potential as a therapeutic target against certain diseases associated with proliferative and metabolic abnormalities. However, the effect on mTOR on PAH has not yet been elucidated. In the present study, a marked downregulation of mTOR was observed in PAH patients. Following construction of a mouse model of PAH by chronic exposure to hypoxia, adenovirus-mediated upregulation of mTOR significantly attenuated right ventricular systolic pressure, right ventricular hypertrophy and wall thickness of pulmonary arterioles, indicating a protective effect of mTOR on PAH. Further analysis confirmed that mTOR overexpression inhibited autophagy triggered by hypoxia through blocking light chain 3 II expression and increasing p62 levels. In vitro, hypoxia enhanced the proliferation of human pulmonary artery endothelial cells (PAECs), which was markedly abrogated by mTOR overexpression. Of note, upregulation of mTOR inhibited the hypoxia-induced autophagy pathway, which contributed to cell proliferation, while silencing of autophagy by RNA interference with ATG5 significantly inhibited cell proliferation. In conclusion, the results of the present study suggested a potential protective effect of mTOR on the progression of PAH by suppressing PAEC proliferation through blocking the autophagic pathway. Therefore, the present study suggested that mTOR is a promising therapeutic agent against PAH.

View Figures

View References

1	Tuder RM, Abman SH, Braun T, et al: Development and pathology of pulmonary hypertension. J Am Coll Cardiol. 54:S3–S9. 2009. View Article : Google Scholar : PubMed/NCBI
2	McLaughlin VV, Davis M and Cornwell W: Pulmonary arterial hypertension. Curr Probl Cardiol. 36:461–517. 2011. View Article : Google Scholar : PubMed/NCBI
3	Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ and Nicolls MR: Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J. 40:1555–1565. 2012. View Article : Google Scholar : PubMed/NCBI
4	Tuder RM, Marecki JC, Richter A, Fijalkowska I and Flores S: Pathology of pulmonary hypertension. Clin Chest Med. 28:23–42. 2007. View Article : Google Scholar : PubMed/NCBI
5	Rabinovitch M: Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 118:2372–2379. 2008. View Article : Google Scholar : PubMed/NCBI
6	Xu W and Erzurum SC: Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension. Compr Physiol. 1:357–372. 2011.PubMed/NCBI
7	Guignabert C, Raffestin B, Benferhat R, et al: Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation. 111:2812–2819. 2005. View Article : Google Scholar : PubMed/NCBI
8	Masri FA, Xu W, Comhair SA, et al: Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 293:L548–L554. 2007. View Article : Google Scholar : PubMed/NCBI
9	Choi AM, Ryter SW and Levine B: Autophagy in human health and disease. N Engl J Med. 368:651–662. 2013. View Article : Google Scholar : PubMed/NCBI
10	Slomovitz BM and Coleman RL: The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res. 18:5856–5864. 2012. View Article : Google Scholar : PubMed/NCBI
11	Wang X, Li L, Niu X, et al: mTOR enhances foam cell formation by suppressing the autophagy pathway. DNA Cell Biol. 33:198–204. 2014. View Article : Google Scholar : PubMed/NCBI
12	Ryter SW, Nakahira K, Haspel JA and Choi AM: Autophagy in pulmonary diseases. Annu Rev Physiol. 74:377–401. 2012. View Article : Google Scholar
13	Zhang H, Gong Y, Wang Z, et al: Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K/Akt/mTOR signal and the inhibition of autophagy under hypoxia. J Cell Mol Med. 18:542–553. 2014. View Article : Google Scholar : PubMed/NCBI
14	Mizumura K, Cloonan SM, Haspel JA and Choi AM: The emerging importance of autophagy in pulmonary diseases. Chest. 142:1289–1299. 2012. View Article : Google Scholar : PubMed/NCBI
15	Nyfeler B, Bergman P, Wilson CJ and Murphy LO: Quantitative visualization of autophagy induction by mTOR inhibitors. Methods Mol Biol. 821:239–250. 2012. View Article : Google Scholar
16	Jung CH, Ro SH, Cao J, Otto NM and Kim DH: mTOR regulation of autophagy. FEBS Lett. 584:1287–1295. 2010. View Article : Google Scholar : PubMed/NCBI
17	Zhang X, Li W, Hou Y, Niu Z, Zhong Y, Zhang Y and Yang S: Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry. Am J Transl Res. 6:267–280. 2014.PubMed/NCBI
18	Veyssier-Belot C and Cacoub P: Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension. Cardiovasc Res. 44:274–282. 1999. View Article : Google Scholar
19	Perros F, Dorfmüller P, Souza R, et al: Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J. 29:937–943. 2007. View Article : Google Scholar
20	Laplante M and Sabatini DM: mTOR signaling in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
21	Wang X, Li L, Li M, et al: Knockdown of mTOR by lentivirus-mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E-deficient mice. Int J Mol Med. 32:1215–1221. 2013.PubMed/NCBI
22	Zoncu R, Efeyan A and Sabatini DM: mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 12:21–35. 2010. View Article : Google Scholar : PubMed/NCBI
23	Stenmark KR, Fagan KA and Frid MG: Hypoxia-induced pulmonary vascular remodeling cellular and molecular mechanisms. Circ Res. 99:675–691. 2006. View Article : Google Scholar : PubMed/NCBI
24	Orr R, Smith LJ and Cuttica MJ: Pulmonary hypertension in advanced chronic obstructive pulmonary disease. Curr Opin Pulm Med. 18:138–143. 2012. View Article : Google Scholar
25	Hoshikawa Y, Ono S, Suzuki S, et al: Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol. 90:1299–1306. 2001.PubMed/NCBI
26	Mizushima N: Autophagy: process and function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
27	Kuma A, Matsui M and Mizushima N: LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy. Autophagy. 3:323–328. 2007. View Article : Google Scholar : PubMed/NCBI
28	Gomez-Arroyo JG, Farkas L, Alhussaini AA, et al: The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol. 302:L363–L369. 2012. View Article : Google Scholar
29	Long L, Yang X, Southwood M, et al: Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res. 112:1159–1170. 2013. View Article : Google Scholar : PubMed/NCBI
30	Ravikumar B, Vacher C, Berger Z, et al: Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 36:585–595. 2004. View Article : Google Scholar : PubMed/NCBI
31	Schaefer CA, Kuhlmann CRW, Weiterer S, et al: Statins inhibit hypoxia-induced endothelial proliferation by preventing calcium-induced ROS formation. Atherosclerosis. 185:290–296. 2006. View Article : Google Scholar
32	Tuder RM, Groves B, Badesch DB and Voelkel NF: Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol. 144:275–285. 1994.PubMed/NCBI
33	Yu L and Hales CA: Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells. J Vasc Res. 48:465–475. 2011. View Article : Google Scholar : PubMed/NCBI
34	Porter KM, Kang BY, Adesina SE, Murphy TC, Hart CM and Sutliff RL: Chronic hypoxia promotes pulmonary artery endothelial cell proliferation through H₂O₂-induced 5-lipoxygenase. PloS One. 9:e985322014. View Article : Google Scholar
35	Kang BY, Kleinhenz JM, Murphy TC and Hart CM: The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 301:L881–L891. 2011. View Article : Google Scholar : PubMed/NCBI
36	Poon A, Eidelman D, Laprise C and Hamid Q: ATG5, autophagy and lung function in asthma. Autophagy. 8:694–695. 2012. View Article : Google Scholar : PubMed/NCBI